Chemomab Therapeutics (CMMB) Stock Chart & Stock Price History $0.98 +0.01 (+1.03%) Closing price 08/6/2025 03:55 PM EasternExtended Trading$0.97 -0.01 (-0.61%) As of 08/6/2025 05:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Chemomab Therapeutics Stock Price Performance The Chemomab Therapeutics (CMMB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 2.00%, with a year-to-date return of -45.86%. In the past month, the stock has decreased 14.78%, reflecting recent market activity. As of the latest close, Chemomab Therapeutics traded at $0.98 with a market cap of $18.48 million and volume of 26,904 shares. Receive CMMB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.39%1 Month Performance-14.78%3 Month Performance-20.33%Year-To-Date Performance-45.86%1 Year Performance-2.00% CMMB Stock Chart for Thursday, August, 7, 2025 CMMB Chart by TradingView Chemomab Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/06/2025$0.97$0.98+1.03%$1.00$0.9726,904 shs$18.48 million08/05/2025$1.00$0.97-3.00%$1.02$0.91122,451 shs$18.29 million08/04/2025$1.03$1.00-2.44%$1.05$0.99161,745 shs$18.86 million08/01/2025$1.07$1.03-4.21%$1.07$1.02106,220 shs$19.33 million07/31/2025$1.08$1.07-0.93%$1.13$1.06151,311 shs$20.18 million07/30/2025$1.09$1.08-0.92%$1.14$1.0663,181 shs$20.37 million07/29/2025$1.09$1.09$1.13$1.0673,808 shs$20.55 million07/28/2025$1.09$1.09$1.20$1.09146,617 shs$20.56 million07/25/2025$1.09$1.09$1.12$1.08129,407 shs$20.56 million07/24/2025$1.10$1.09-0.91%$1.11$1.0797,058 shs$20.56 million Get the Latest News and Ratings for CMMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/23/2025$1.12$1.10-1.79%$1.12$1.09243,080 shs$20.74 million07/22/2025$1.10$1.12+1.82%$1.21$1.0977,159 shs$21.12 million07/21/2025$1.13$1.10-2.65%$1.14$1.09130,615 shs$20.75 million07/18/2025$1.13$1.13$1.14$1.11128,246 shs$21.31 million07/17/2025$1.14$1.13-0.88%$1.15$1.12188,433 shs$21.31 million07/16/2025$1.15$1.14-0.87%$1.18$1.13167,180 shs$21.50 million07/15/2025$1.17$1.15-1.71%$1.19$1.1397,772 shs$21.69 million07/14/2025$1.16$1.17+1.18%$1.22$1.15132,997 shs$22.06 million07/11/2025$1.16$1.16-0.32%$1.23$1.1668,068 shs$21.81 million07/10/2025$1.17$1.16-0.85%$1.20$1.15268,123 shs$21.88 million07/09/2025$1.16$1.17+0.86%$1.20$1.15127,382 shs$22.07 million07/08/2025$1.15$1.16+0.87%$1.19$1.14128,440 shs$21.88 million07/07/2025$1.18$1.15-2.54%$1.22$1.14138,652 shs$21.69 million Related Companies CABA Stock Chart MIST Stock Chart QNCX Stock Chart ELUT Stock Chart BYSI Stock Chart SRZN Stock Chart CELU Stock Chart IMMX Stock Chart CRVO Stock Chart CNTX Stock Chart Receive CMMB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CMMB) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemomab Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CMMB Stock Alerts